止血診断分析及び試薬の日本市場2019-2023

【英語タイトル】Japan Hemostasis Diagnostic Analyzers and Reagents Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Venture Planning Groupが出版した調査資料(VPG906181)・商品コード:VPG906181
・発行会社(調査会社):Venture Planning Group
・発行日:2019年6月
・ページ数:402
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:日本
・産業分野:医療
◆販売価格オプション(消費税別)
Local PDFUSD6,100 ⇒換算¥664,900見積依頼/購入/質問フォーム
Global PDFUSD9,500 ⇒換算¥1,035,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. 

The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major
instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of
major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive market
segmentation analysis, including:

   – Hospitals
   – Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures
by market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies
and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion
opportunities with significant market appeal.

- “Ideal” product models with tentative
prices and operating characteristics.

- Alternative market penetration
strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Contains 402 pages and 35 tables

【レポートの目次】

http://www.LeadingMarketResearch.com/pdffiles/LOTJapanCoagTestingMarketSalesForecastsupplierSharesCompetitiveStrategies.pdf

http://www.vpgcorp.com/webfiles/Coagulation/CoagulationCompanyProfiled.pdf

【掲載企業】

Competitive Assessments

Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher


★調査レポート[止血診断分析及び試薬の日本市場2019-2023] (コード:VPG906181)販売に関する免責事項を必ずご確認ください。
★調査レポート[止血診断分析及び試薬の日本市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆